WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: APRIL ISSUE PUBLISHED

    APRIL 2026 Issue has been successfully launched on APRIL 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR April 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

EVALUATION OF MOLECULAR FINDINGS WITH CLINICAL SYMPTOMS, ACUTE INFLAMMATORY MARKERS AND HAEMATOLOGICAL PARAMETERS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER IN NINEVEH PROVINCE

*Dr. Muwafaq Mohsin Thalaj, Professor Dr. Khalid N. M. Al-Kheroo

ABSTRACT

Background: Familial Mediterranean fever (FMF) also known as recurrent polyserositis, is an autosomal recessive autoinflammatory disorder characterized mainly by brief recurrent episodes of peritonitis, pleuritis, and arthritis, usually with accompanying fever. Attacks often begin in childhood; in approximately 90% of cases, clinical onset is before age 20 years. As the name indicates, FMF occurs within families and is most common in individuals of Mediterranean descent. Objectives: To investigate the relationship between genetic mutations, clinical symptoms, and acute phase reactants, as well as haematological parameters for patients with familial Mediterranean fever in Nineveh province. Methods: This retrospective cohort study included sixty patients aged above 15 years, with clinical features of Familial Mediterranean Fever according to Tel Hashomer and Livneh criteria for adults, and the genetic mutations MEFV GENE (homozygous and heterozygous). The patients were clinically evaluated and screened for the most common 12 MEFV different mutations frequently detected in the Mediterranean region using the CE/IVD-labelled FMF Strip Assay (Vienna Lab Diagnostics, Vienna, Austria). This test is based on reverse hybridization of biotinylated PCR products on immobilized oligos for mutations and controls in a parallel array of allele-specific oligonucleotides. Results: Among 60 patients with FMF with MEFV gene mutations (heterozygous and homozygous), it demonstrated that the most frequent heterozygous was M694I in 12 patients, while homozygous was M694V in 12 patients. The most frequent double mutation was double heterozygous E148Q and M694I in 6 patients. Males were more common than females in both groups of mutations. Abdominal pain and fever were more frequently in heterozygous group of mutations. At the same time, acute phase reactants erythrocyte sedimentation rate (ESR) and c-reactive protein (CRP) as well as complete blood count (CBC) (neutrophils and lymphocytes) were significantly elevated in the homozygous group of mutations. Conclusions: The most common mutations were M694V and M694I, homozygous and heterozygous, respectively. Whereas acute-phase reactants and white blood cells (WBC) were more significantly elevated in the homozygous group than in the heterozygous group. Heterozygous mutations express more symptoms.

[Full Text Article] [Download Certificate]